Can-Fite Biopharma (NYSEAMERICAN: CANF) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that its data has been selected for a coming presentation, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The coming presentation; what we’re seeing … Read more
Can-Fite BioPharma Ltd. (NYSEAMERICAN: CANF) is having an overwhelmingly strong start to the trading session this morning after the company announced news surrounding a Phase II clinical trial. Of course, the update was positive, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The clinical update; what we’re … Read more
CAN-FITE BioPharma Ltd. (NYSEAMERICAN: CANF) is having a relatively strong start to the trading session this morning, and for good reason. The company provided an update with regard to new pre-clinical data supporting an ongoing Phase II clinical study. Of course, the positive news excited investors who are pushing the stock upward in the market … Read more
Can Fite Biopharma Ltd (ADR) (NYSEAMERICAN: CANF) is having an incredible day in the market today, and for good reason, the company announced a payment of about $2.2 million that was received. This proved to be exciting news among investors, leading to strong gains in the value of the stock. Today, we’ll talk about the payment, … Read more
Can Fite Biopharma Ltd (ADR) (NYSE: CANF) is having an incredibly strong morning in the market this morning after announcing that it has received approval for a key Phase III trial. This of course led to excitement among investors, causing a frenzy and pushing the stock upward. As is normally the case, our partners at … Read more